The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH) Clinical Center awarded a $10,901.52 firm fixed-price purchase order to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The contract, awarded on July 31, 2024, runs through January 30, 2025 and is for the supply of the UVADEX medication used in the CELLEX Photopheresis System. Therakos, Inc. is the prime contractor and no set-aside designation was used for this award. The company also holds a $3.49 million Blanket Purchase Agreement with the Department of Veterans Affairs (VA) for photopheresis light kits, UVADEX solution, and photopheresis systems, as well as a $750,000 Federal Supply Schedule contract with the VA for pharmaceuticals and drugs. These contract vehicles allow various federal healthcare facilities to order Therakos' specialized photopheresis products and services to support patient care and research initiatives.
Generated 7/31/24, 9:37 AM